Recursion Pharmaceuticals Inc. (RXRX)
Market Open
2 May, 15:46
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 84
+0.34
+6.18%
$
1.72B Market Cap
- P/E Ratio
0% Div Yield
439,987 Volume
-1.72 Eps
$ 5.5
Previous Close Day Range
5.6 5.88
Year Range
3.79 12.36
Earnings results expected in 5 days
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| RXRX Recursion Pharmaceuticals Inc. 7 May 2025 (5 Days) | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 25 Feb 2025 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 7 Nov 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 Nov 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 8 Aug 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 Aug 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 3 Jun 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 20 May 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 May 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 27 Feb 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 26 Feb 2024 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 9 Nov 2023 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 7 Nov 2023 | | - Cons. EPS | - EPS |
| RXRX Recursion Pharmaceuticals Inc. 6 Nov 2023 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
